Management of patients with epidermal growth factor receptor mutation-positive (EGFRm plus ) non-small cell lung cancer (NSCLC) after radiological progression to first-line therapy with gefitinib.

被引：0

作者：

Hosomi, Yukio

Tanai, Chiharu

Yoh, Kiyotaka

Goto, Yasushi

Ohashi, Yasuo

Kunitoh, Hideo

机构：

[1] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan

[2] NTT Med Ctr, Div Respirol, Tokyo, Japan

[3] Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan

[4] Natl Canc Ctr, Tokyo, Japan

[5] Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo 112, Japan

[6] Japanese Red Cross Med Ctr, Tokyo, Japan

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e19124

引用

页数：1